Cost comparison of andexanet versus prothrombin complex concentrates for direct factor Xa inhibitor reversal after hemorrhage
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cost comparison of andexanet versus prothrombin complex concentrates for direct factor Xa inhibitor reversal after hemorrhage
Authors
Keywords
-
Journal
JOURNAL OF THROMBOSIS AND THROMBOLYSIS
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-10-31
DOI
10.1007/s11239-019-01973-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Full Study Report of Andexanet Alfa for Bleeding Associated with Factor Xa Inhibitors
- (2019) Stuart J. Connolly et al. NEW ENGLAND JOURNAL OF MEDICINE
- The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation
- (2018) Jan Steffel et al. EUROPEAN HEART JOURNAL
- Prothrombin Complex Concentrate for Major Bleeding on Factor Xa Inhibitors: A Prospective Cohort Study
- (2018) Peter Gross et al. THROMBOSIS AND HAEMOSTASIS
- Antithrombotic Therapy for Atrial Fibrillation
- (2018) Gregory Y.H. Lip et al. CHEST
- The Reversal of Bleeding Caused by New Oral Anticoagulants (NOACs): A Systematic Review and Meta-Analysis
- (2018) Sariya Udayachalerm et al. CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
- Tolerability and effectiveness of 4-factor prothrombin complex concentrate (4F-PCC) for warfarin and non-warfarin reversals
- (2018) M. Santibanez et al. JOURNAL OF CRITICAL CARE
- Evaluation of the Use of Low-Dose 4-Factor Prothrombin Complex Concentrate in the Reversal of Direct Oral Anticoagulants in Bleeding Patients
- (2018) Teresa A. Allison et al. JOURNAL OF INTENSIVE CARE MEDICINE
- 2017 ACC Expert Consensus Decision Pathway on Management of Bleeding in Patients on Oral Anticoagulants
- (2017) Gordon F. Tomaselli et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Idarucizumab for Dabigatran Reversal — Full Cohort Analysis
- (2017) Charles V. Pollack et al. NEW ENGLAND JOURNAL OF MEDICINE
- Guideline for Reversal of Antithrombotics in Intracranial Hemorrhage
- (2016) Jennifer A. Frontera et al. CRITICAL CARE MEDICINE
- When and how to use antidotes for the reversal of direct oral anticoagulants: guidance from the SSC of the ISTH
- (2016) J. H. Levy et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Reversal strategies for non-vitamin K antagonist oral anticoagulants: a critical appraisal of available evidence and recommendations for clinical management—a joint position paper of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy and European Society of Cardiology Working Group on Thrombosis
- (2015) Alexander Niessner et al. EUROPEAN HEART JOURNAL
- Guideline for Reversal of Antithrombotics in Intracranial Hemorrhage
- (2015) Jennifer A. Frontera et al. Neurocritical Care
- Efficacy and Safety of a 4-Factor Prothrombin Complex Concentrate in Patients on Vitamin K Antagonists Presenting With Major Bleeding
- (2013) Ravi Sarode et al. CIRCULATION
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started